Christopher Fuglesang, Director, 10% Owner at Pandion Therapeutics, Inc. (PAND), bought 2,131,135 shares at $18.00 ($13.0M) on 2020-07-21, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,408,913 | $0 | 0.0% |
| 2 | $18.00 | 722,222 | $13.0M | 100.0% |
| Total | $6.10 avg | 2,131,135 | $13.0M | 100% |
| Filing → |